July.28.2022, Singapore ------ Azenta, Inc. (Nasdaq: AZTA), the leading life sciences company today announced the opening of its new China headquarters in Suzhou, which serves as the hub for Azenta's operations in the Asia Pacific region. This project is the largest capital investment to date for Azenta and consists of over 200,000 square feet (Approx. 18,580 square meter) of laboratory and office space. The new facility consolidates multiple leased spaces into a single owned facility and significantly expands the capacity of Azenta labs in China.
More than 800 Azenta employees will be working in the new building, which features intelligent environmental controls that are vital for high quality laboratory operations. The building is also home to Azenta's largest center for genomics services coupled with high performance computing and data management capabilities.
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. Enabling impactful breakthroughs and therapies to market faster, Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. As of December 1st, the company changed its name and ticker to Azenta, Inc. (Nasdaq: AZTA) from Brooks Automation, Inc, (Nasdaq: BRKS).
For more information, please visit: